Literature DB >> 24661593

Factors associated with the change in prevalence of cardiomyopathy at delivery in the period 2000-2009: a population-based prevalence study.

C A Grotegut1, E V Kuklina, K J Anstrom, R P Heine, W M Callaghan, E R Myers, A H James.   

Abstract

OBJECTIVE: Cardiomyopathy (CM) at delivery is increasing in prevalance. The objective of this study was to determine which medical conditions are attributable to this increasing prevalance.
DESIGN: Population prevalence study from 2000 to 2009.
SETTING: The Nationwide Inpatient Sample (NIS). SAMPLE: Pregnant women admitted for delivery were identified in the NIS for the years 2000-2009.
METHODS: Temporal trends in pre-existing medical conditions and in medical and obstetric complications at delivery admissions were determined by linear regression. The change in the prevalence of CM among all pregnant women was compared with the change in the prevalance of CM among pregnant women without pre-existing conditions or complications. MAIN OUTCOME MEASURE: Prevalence of CM.
RESULTS: The prevalence of CM increased from 0.25 per 1000 deliveries in 2000 to 0.43 per 1000 deliveries in 2009 (P < 0.0001). Women with chronic hypertension had increased odds of developing CM compared with women without chronic hypertension (odds ratio, OR, 13.2; 95% confidence interval, 95% CI, 12.5-13.7). The linear increase in chronic hypertension over the 10-year period was the single identified pre-existing medical condition that explained the increasing prevalence of CM at delivery (P = 0.005 for the differences in slopes for linear trends).
CONCLUSIONS: Pregnant women with chronic hypertenion are at an increased risk for CM at delivery, and the increasing prevalence of chronic hypertension is an important factor associated with the increasing prevalence of CM at the time of delivery. Among women without chronic hypertension, the prevalence of CM at delivery did not change during the time period.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Cardiomyopathy; hypertension; mortality; nationwide inpatient sample; pregnancy

Mesh:

Year:  2014        PMID: 24661593      PMCID: PMC4175993          DOI: 10.1111/1471-0528.12726

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  30 in total

1.  Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.

Authors:  G D Pearson; J C Veille; S Rahimtoola; J Hsia; C M Oakley; J D Hosenpud; A Ansari; K L Baughman
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

2.  Central hemodynamic assessment of normal term pregnancy.

Authors:  S L Clark; D B Cotton; W Lee; C Bishop; T Hill; J Southwick; J Pivarnik; T Spillman; G R DeVore; J Phelan
Journal:  Am J Obstet Gynecol       Date:  1989-12       Impact factor: 8.661

3.  Natural course of peripartum cardiomyopathy.

Authors:  J G Demakis; S H Rahimtoola; G C Sutton; W R Meadows; P B Szanto; J R Tobin; R M Gunnar
Journal:  Circulation       Date:  1971-12       Impact factor: 29.690

4.  Peripartum cardiomyopathy.

Authors:  J G Demakis; S H Rahimtoola
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

5.  Blood volume during pregnancy. Significance of plasma and red cell volumes.

Authors:  C J Lund; J C Donovan
Journal:  Am J Obstet Gynecol       Date:  1967-06-01       Impact factor: 8.661

6.  Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality.

Authors:  Margaret A Harper; Robert E Meyer; Cynthia J Berg
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

7.  Pregnancy-related mortality in the United States, 1991-1997.

Authors:  Cynthia J Berg; Jeani Chang; William M Callaghan; Sara J Whitehead
Journal:  Obstet Gynecol       Date:  2003-02       Impact factor: 7.661

8.  Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997.

Authors:  Sara J Whitehead; Cynthia J Berg; Jeani Chang
Journal:  Obstet Gynecol       Date:  2003-12       Impact factor: 7.661

9.  International Classification of Diseases-9th revision coding for preeclampsia: how accurate is it?

Authors:  Stacie E Geller; Shirin Ahmed; Monique L Brown; Suzanne M Cox; Deborah Rosenberg; Sarah J Kilpatrick
Journal:  Am J Obstet Gynecol       Date:  2004-06       Impact factor: 8.661

10.  Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events?

Authors:  F G Cunningham; J A Pritchard; G D Hankins; P L Anderson; M J Lucas; K F Armstrong
Journal:  Obstet Gynecol       Date:  1986-02       Impact factor: 7.661

View more
  2 in total

Review 1.  [Recent standards in management of obstetric anesthesia].

Authors:  Maximiliaan van Erp; Clemens Ortner; Stefan Jochberger; Klaus Ulrich Klein
Journal:  Wien Med Wochenschr       Date:  2017-07-25

2.  A national update on rates of postpartum haemorrhage and related interventions.

Authors:  Homa K Ahmadzia; Chad A Grotegut; Andra H James
Journal:  Blood Transfus       Date:  2020-05-15       Impact factor: 3.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.